These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32339385)

  • 1. Magnesium sulphate for prevention of cerebral palsy: if not now, when?
    Grobman WA
    BJOG; 2020 Sep; 127(10):1226. PubMed ID: 32339385
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: At which gestational ages should magnesium sulphate be given to women at risk of preterm birth?
    Larsen ML; Krebs L; Rackauskaite G; Hoei-Hansen CE; Greisen G
    BJOG; 2020 Sep; 127(10):1295-1296. PubMed ID: 32394601
    [No Abstract]   [Full Text] [Related]  

  • 3. Authors' reply re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial: Time range for treatment with magnesium sulphate.
    Wolf HT; Brok J; Henriksen TB; Hegaard HK; Greisen G; Weber T; Pryds O; Salvig JD; Hedegaard M; Pinborg A; Huusom LD
    BJOG; 2020 Sep; 127(10):1296-1297. PubMed ID: 32427415
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnesium sulphate for the prevention of cerebral palsy in Australia and New Zealand.
    Bain E; Goodchild L; Lontis R; McIntyre S; Ashwood P; Bubner T; Middleton P; Crowther C
    Aust Nurs J; 2013 Jul; 21(1):34-7. PubMed ID: 23930314
    [No Abstract]   [Full Text] [Related]  

  • 5. What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ; Hirtz D;
    Semin Perinatol; 2016 Aug; 40(5):303-6. PubMed ID: 27117179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal magnesium for preterm delivery reduces risk of cerebral palsy among surviving very preterm infants.
    Paulsen ME; Dietz RM
    Acta Paediatr; 2018 Jan; 107(1):175. PubMed ID: 29083069
    [No Abstract]   [Full Text] [Related]  

  • 7. Antenatal magnesium sulfate treatment for women at risk of preterm birth is safe and might decrease the risk of cerebral palsy.
    Huusom LD; Wolf HT
    BMJ Evid Based Med; 2018 Oct; 23(5):195-196. PubMed ID: 29921710
    [No Abstract]   [Full Text] [Related]  

  • 8. Magnesium Sulfate and Novel Therapies to Promote Neuroprotection.
    Jameson RA; Bernstein HB
    Clin Perinatol; 2019 Jun; 46(2):187-201. PubMed ID: 31010555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal obesity and neuroprotective magnesium sulfate.
    McPherson J; Smiley S; Stamilio D
    Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with magnesium sulphate in pre-term birth: a systematic review and meta-analysis of observational studies.
    Wolf HT; Hegaard HK; Greisen G; Huusom L; Hedegaard M
    J Obstet Gynaecol; 2012 Feb; 32(2):135-40. PubMed ID: 22296422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to uptake of magnesium sulphate for neuroprotection in preterm births <30 weeks at Christchurch Hospital.
    Pang J
    N Z Med J; 2017 Jul; 130(1458):52-53. PubMed ID: 28694540
    [No Abstract]   [Full Text] [Related]  

  • 12. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
    Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
    Doyle LW; Crowther CA; Middleton P; Marret S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral palsy in very low birth weight infants, pre-eclampsia and magnesium sulphate.
    Blair E; Palmer L; Stanley F
    Pediatrics; 1996 May; 97(5):780-2. PubMed ID: 8628635
    [No Abstract]   [Full Text] [Related]  

  • 15. Antenatal magnesium sulfate for neuroprotection before preterm birth?
    Stanley FJ; Crowther C
    N Engl J Med; 2008 Aug; 359(9):962-4. PubMed ID: 18753653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
    Marret S; Ancel PY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal pharmacotherapy 3: magnesium sulfate.
    Namouz-Haddad S; Koren G
    J Obstet Gynaecol Can; 2013 Dec; 35(12):1101-1104. PubMed ID: 24405877
    [No Abstract]   [Full Text] [Related]  

  • 19. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
    Ow LL; Kennedy A; McCarthy EA; Walker SP
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium sulfate for neuroprotection in patients at risk for early preterm delivery: not yet.
    Sibai BM
    Am J Obstet Gynecol; 2011 Oct; 205(4):296-7. PubMed ID: 22083053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.